scholarly article | Q13442814 |
P819 | ADS bibcode | 1998PNAS...95.7731K |
P356 | DOI | 10.1073/PNAS.95.13.7731 |
P932 | PMC publication ID | 22740 |
P698 | PubMed publication ID | 9636219 |
P5875 | ResearchGate publication ID | 13648849 |
P50 | author | Adelaida de la Calle | Q5657499 |
Patricia S. Goldman-Rakic | Q510587 | ||
P2093 | author name string | Gutierrez A | |
Khan ZU | |||
Mrzljak L | |||
P2860 | cites work | Abnormal synaptic plasticity in the striatum of mice lacking dopamine D2 receptors | Q28512698 |
Electron microscopic analysis of D1 and D2 dopamine receptor proteins in the dorsal striatum and their synaptic relationships with motor corticostriatal afferents | Q28564581 | ||
Pituitary lactotroph hyperplasia and chronic hyperprolactinemia in dopamine D2 receptor-deficient mice | Q28586296 | ||
Alterations in dopamine release but not dopamine autoreceptor function in dopamine D3 receptor mutant mice | Q28593197 | ||
Antibodies to the human gamma 2 subunit of the gamma-aminobutyric acidA/benzodiazepine receptor | Q28609362 | ||
D1 and D2 dopamine receptor-regulated gene expression of striatonigral and striatopallidal neurons | Q29615480 | ||
Differential autoreceptor control of somatodendritic and axon terminal dopamine release in substantia nigra, ventral tegmental area, and striatum | Q34432376 | ||
Multiple D2 dopamine receptors produced by alternative RNA splicing | Q35164518 | ||
A common action of clozapine, haloperidol, and remoxipride on D1- and D2-dopaminergic receptors in the primate cerebral cortex | Q35229075 | ||
Increased abundance of alternatively spliced forms of D2 dopamine receptor mRNA after denervation | Q37462990 | ||
Dopamine receptors and schizophrenia | Q41011180 | ||
Synaptic regulation of mesocorticolimbic dopamine neurons | Q41132697 | ||
Localization of dopamine D4 receptors in GABAergic neurons of the primate brain | Q41198273 | ||
Linking the family of D2 receptors to neuronal circuits in human brain: insights into schizophrenia | Q41482408 | ||
The cortical dopamine system: role in memory and cognition | Q41609938 | ||
Solubilisation of high-affinity dopamine receptors | Q41644779 | ||
Ultrastructural localization of D2 receptor-like immunoreactivity in midbrain dopamine neurons and their striatal targets | Q48226154 | ||
Characterization of the dopaminergic innervation of the primate frontal cortex using a dopamine-specific antibody | Q48298303 | ||
Central D2-dopamine receptor occupancy in relation to antipsychotic drug effects: a double-blind PET study of schizophrenic patients | Q48332281 | ||
Loss of autoreceptor function in dopaminergic neurons from dopamine D2 receptor deficient mice | Q48745660 | ||
A rapid filtration assay for soluble receptors using polyethylenimine-treated filters | Q48789289 | ||
Evidence that excitatory amino acids mediate afferent input to the primate somatosensory thalamus | Q48960285 | ||
Involvement of D2 dopamine receptors in the nucleus accumbens in the opiate withdrawal syndrome. | Q52023379 | ||
Alternative splicing directs the expression of two D2 dopamine receptor isoforms. | Q55058608 | ||
Distribution of dopamine D2 receptor mRNA splice variants in the rat by solution mhybridization/protection assay | Q67900414 | ||
Functional anatomy of the basal ganglia. II. The place of subthalamic nucleus and external pallidum in basal ganglia circuitry | Q72144620 | ||
Short and long form gamma 2 subunits of the GABAA/benzodiazepine receptors | Q72729029 | ||
Regulation of dopamine D1 and D2 receptors on striatal acetylcholine release in rats | Q73472317 | ||
P433 | issue | 13 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | dopamine | Q170304 |
P304 | page(s) | 7731-7736 | |
P577 | publication date | 1998-06-01 | |
P1433 | published in | Proceedings of the National Academy of Sciences of the United States of America | Q1146531 |
P1476 | title | Prominence of the dopamine D2 short isoform in dopaminergic pathways | |
P478 | volume | 95 |
Q34394954 | A Drosophila dopamine 2-like receptor: Molecular characterization and identification of multiple alternatively spliced variants |
Q34017591 | A positron emission tomography study of nigro-striatal dopaminergic mechanisms underlying attention: implications for ADHD and its treatment |
Q40622353 | A region of the third intracellular loop of the short form of the D2 dopamine receptor dictates Gi coupling specificity |
Q33578546 | ANKK1 and DRD2 pharmacogenetics of disulfiram treatment for cocaine abuse |
Q46880735 | Abnormal striatal dopaminergic synapses in National NeuroAIDS Tissue Consortium subjects with HIV encephalitis |
Q28142501 | Addiction, dopamine, and the molecular mechanisms of memory |
Q43780931 | Agonist-independent and -dependent oligomerization of dopamine D(2) receptors by fusion to fluorescent proteins |
Q33859015 | Alcoholism and alternative splicing of candidate genes |
Q37560684 | Alternative splicing of G protein-coupled receptors: physiology and pathophysiology |
Q44555526 | Alternative splicing of the muscarinic acetylcholine receptor GAR-3 in Caenorhabditis elegans |
Q34115031 | An astroglia-linked dopamine D2-receptor action in prefrontal cortex |
Q45957779 | Association between the DRD2-141C Insertion/Deletion polymorphism and schizophrenia. |
Q46513883 | Association of multiple DRD2 polymorphisms with anorexia nervosa |
Q40901858 | Basal signaling activity of human dopamine D2L receptor demonstrated with an ecdysone-inducible mammalian expression system |
Q35626928 | Behavioral and neurochemical changes in mesostriatal dopaminergic regions of the rat after chronic administration of the cannabinoid receptor agonist WIN55,212-2. |
Q44326757 | Biphasic role of dopamine on female sexual behaviour via D2 receptors in the mediobasal hypothalamus |
Q48682603 | Cane Toad Skin Extract-Induced Upregulation and Increased Interaction of Serotonin 2A and D2 Receptors via Gq/11 Signaling Pathway in CLU213 Cells |
Q37104197 | Cannabinoid-induced enhanced interaction and protein levels of serotonin 5-HT(2A) and dopamine D₂ receptors in rat prefrontal cortex |
Q34466444 | Chronic and acute regulation of Na+/Cl- -dependent neurotransmitter transporters: drugs, substrates, presynaptic receptors, and signaling systems |
Q39649375 | Chronic ethanol exposure changes dopamine D2 receptor splicing during retinoic acid-induced differentiation of human SH-SY5Y cells |
Q46501122 | Cocaine-induced adaptation of dopamine D2S, but not D2L autoreceptors |
Q42046489 | Constitutive oligomerization of human D2 dopamine receptors expressed in Spodoptera frugiperda 9 (Sf9) and in HEK293 cells. Analysis using co-immunoprecipitation and time-resolved fluorescence resonance energy transfer |
Q44765935 | Consuming a low-fat diet from weaning to adulthood reverses the programming of food preferences in male, but not in female, offspring of 'junk food'-fed rat dams |
Q43868487 | Contrasting changes in DRD1 and DRD2 splice variant expression in schizophrenia and affective disorders, and associations with SNPs in postmortem brain. |
Q34394799 | Control of lactotrop proliferation by dopamine: essential role of signaling through D2 receptors and ERKs |
Q48328590 | D1 receptor in interneurons of macaque prefrontal cortex: distribution and subcellular localization. |
Q37130639 | D2 dopamine receptor activation facilitates endocannabinoid-mediated long-term synaptic depression of GABAergic synaptic transmission in midbrain dopamine neurons via cAMP-protein kinase A signaling |
Q64777182 | DRD2 Genotype-Based Variants Modulates D2 Receptor Distribution in Ventral Striatum |
Q50695782 | DRD2 genotype predicts prefrontal activity during working memory after stimulation of D2 receptors with bromocriptine. |
Q36054572 | DRD2 polymorphisms modulate reward and emotion processing, dopamine neurotransmission and openness to experience |
Q47985284 | Detection of phasic dopamine by D1 and D2 striatal medium spiny neurons |
Q40085912 | Differential signaling of dopamine-D2S and -D2L receptors to inhibit ERK1/2 phosphorylation |
Q28138415 | Distinct functions of the two isoforms of dopamine D2 receptors |
Q36075672 | Distinct regulation of dopamine D2S and D2L autoreceptor signaling by calcium. |
Q34923951 | Distinct roles of dopamine D2L and D2S receptor isoforms in the regulation of protein phosphorylation at presynaptic and postsynaptic sites |
Q36162473 | Dopamine D(2) Antagonist-Induced Striatal Nur77 Expression Requires Activation of mGlu5 Receptors by Cortical Afferents |
Q24604923 | Dopamine D2 and D3 receptors are linked to the actin cytoskeleton via interaction with filamin A |
Q92351278 | Dopamine D2L Receptor Deficiency Causes Stress Vulnerability through 5-HT1A Receptor Dysfunction in Serotonergic Neurons |
Q41653847 | Dopamine D2L Receptor Is Required for Visual Discrimination and Reversal Learning |
Q24290422 | Dopamine D5 receptors of rat and human brain |
Q43596180 | Dopamine mediation of the feeding response to violations of spatial and temporal expectancies. |
Q82029300 | Dopamine receptor pharmacology |
Q22251247 | Dopamine release in the basal ganglia |
Q33888216 | Dopamine spillover after quantal release: rethinking dopamine transmission in the nigrostriatal pathway |
Q36593856 | Dopamine transporter DAT and receptor DRD2 variants affect risk of lethal cocaine abuse: a gene-gene-environment interaction |
Q24300744 | Dopamine transporter cell surface localization facilitated by a direct interaction with the dopamine D2 receptor |
Q42503430 | Ectopic expression of TrKA in the adult rat basal ganglia induces both nerve growth factor-dependent and -independent neuronal responses |
Q48180557 | Effects of Long-Term Alcohol Drinking on the Dopamine D2 Receptor: Gene Expression and Heteroreceptor Complexes in the Striatum in Rats |
Q92905941 | Effects of Stathmin 1 Gene Knockout on Behaviors and Dopaminergic Markers in Mice Exposed to Social Defeat Stress |
Q57293380 | Effects of social defeat stress on dopamine D2 receptor isoforms and proteins involved in intracellular trafficking |
Q36733481 | Evidence for Noncanonical Neurotransmitter Activation: Norepinephrine as a Dopamine D2-Like Receptor Agonist |
Q44930076 | Evolution and expression of D2 and D3 dopamine receptor genes in zebrafish. |
Q36211455 | Existence and theoretical aspects of homomeric and heteromeric dopamine receptor complexes and their relevance for neurological diseases |
Q42077769 | Extrastriatal dopaminergic abnormalities of DA homeostasis in Parkinson's patients with medication-induced pathological gambling: a [11C] FLB-457 and PET study. |
Q36449651 | Functional Genetic Variation in Dopamine Signaling Moderates Prefrontal Cortical Activity During Risky Decision Making. |
Q45782081 | Functional connectivity in healthy subjects is nonlinearly modulated by the COMT and DRD2 polymorphisms in a functional system-dependent manner. |
Q44492027 | Functional coupling between heterologously expressed dopamine D(2) receptors and KCNQ channels |
Q37092462 | Functional variants of the dopamine receptor D2 gene modulate prefronto-striatal phenotypes in schizophrenia. |
Q64240320 | Genetic labeling reveals temporal and spatial expression pattern of D2 dopamine receptor in rat forebrain |
Q37201805 | Genetically determined interaction between the dopamine transporter and the D2 receptor on prefronto-striatal activity and volume in humans. |
Q35634676 | Gray-matter volume, midbrain dopamine D2/D3 receptors and drug craving in methamphetamine users. |
Q37376944 | HIV-related cognitive impairment shows bi-directional association with dopamine receptor DRD1 and DRD2 polymorphisms in substance-dependent and substance-independent populations |
Q39735652 | Heart-type fatty acid binding protein regulates dopamine D2 receptor function in mouse brain |
Q40278018 | Heteromeric nicotinic acetylcholine-dopamine autoreceptor complexes modulate striatal dopamine release. |
Q33964443 | High-affinity dopamine D2/D3 PET radioligands 18F-fallypride and 11C-FLB457: a comparison of kinetics in extrastriatal regions using a multiple-injection protocol |
Q64999981 | Hypofunctional Dopamine Uptake and Antipsychotic Treatment-Resistant Schizophrenia. |
Q39356115 | Identification and characterization of a novel class of atypical dopamine receptor agonists |
Q36986026 | Identification of G protein-coupled receptors required for vitellogenin uptake into the oocytes of the red flour beetle, Tribolium castaneum |
Q48496117 | Identification of two functionally distinct endosomal recycling pathways for dopamine D₂ receptor. |
Q36778973 | Insights into the role of dopamine receptor systems in learning and memory |
Q24632803 | Integrated signaling in heterodimers and receptor mosaics of different types of GPCRs of the forebrain: relevance for schizophrenia |
Q37958076 | Integrating PET with behavioral neuroscience using RatCAP tomography |
Q34662050 | Intronic polymorphisms affecting alternative splicing of human dopamine D2 receptor are associated with cocaine abuse |
Q85122462 | Isoform-specific uncoupling of the D2 dopamine receptors subtypes |
Q44350735 | Kappa-opioid agonist U69593 potentiates locomotor sensitization to the D2/D3 agonist quinpirole: pre- and postsynaptic mechanisms |
Q83223726 | L-Dopa activates histaminergic neurons |
Q39211780 | Lack of influence of DAT1 and DRD2 gene variants on antidepressant response in generalized anxiety disorder |
Q33714838 | Ligand-induced regulation and localization of cannabinoid CB1 and dopamine D2L receptor heterodimers |
Q24658338 | Looking for the role of cannabinoid receptor heteromers in striatal function |
Q35212984 | Loss of dopamine D2 receptors increases parvalbumin-positive interneurons in the anterior cingulate cortex. |
Q30490410 | Midbrain dopamine receptor availability is inversely associated with novelty-seeking traits in humans |
Q43086685 | Molecular cloning of bullfrog D2 dopamine receptor cDNA: Tissue distribution of three isoforms of D2 dopamine receptor mRNA. |
Q36353466 | Network-Dependent Modulation of COMT and DRD2 Polymorphisms in Healthy Young Adults. |
Q82029336 | Neurochemistry of Parkinson's disease |
Q47877292 | New dopamine receptor, D2(Longer), with unique TG splice site, in human brain |
Q52315876 | Nigrostriatal and Mesolimbic D2/3 Receptor Expression in Parkinson's Disease Patients with Compulsive Reward-Driven Behaviors. |
Q37381378 | Normalizing dopamine D2 receptor-mediated responses in D2 null mutant mice by virus-mediated receptor restoration: comparing D2L and D2S. |
Q28217014 | Nuclear localization of L-type glutaminase in mammalian brain |
Q48514864 | Occupancy of striatal and extrastriatal dopamine D2 receptors by clozapine and quetiapine |
Q36747324 | Paradoxical dopaminergic drug effects in extraversion: dose- and time-dependent effects of sulpiride on EEG theta activity |
Q40569640 | Parvalbumin neuron circuits and microglia in three dopamine-poor cortical regions remain sensitive to amphetamine exposure in the absence of hyperthermia, seizure and stroke |
Q63951925 | Pharmacological blockade of dopamine D2 receptors by aripiprazole is not associated with striatal sensitization |
Q36300098 | Polymorphisms in human dopamine D2 receptor gene affect gene expression, splicing, and neuronal activity during working memory. |
Q39635275 | Polypyrimidine tract-binding protein 1 regulates the alternative splicing of dopamine receptor D2 |
Q92636400 | Preferential Coupling of Dopamine D2S and D2L Receptor Isoforms with Gi1 and Gi2 Proteins-In Silico Study |
Q43151055 | Prefrontal inositol triphosphate is molecular correlate of working memory in nonhuman primates. |
Q45250006 | Presynaptic D1 dopamine receptors in primate prefrontal cortex: target-specific expression in the glutamatergic synapse. |
Q35544292 | Presynaptic regulation of dopaminergic neurotransmission |
Q41271272 | Putative presynaptic dopamine dysregulation in schizophrenia is supported by molecular evidence from post-mortem human midbrain |
Q42948713 | Repeated administration of methamphetamine blocked cholecystokinin-octapeptide injection-induced c-fos mRNA expression without change in capsaicin-induced junD mRNA expression in rat cerebellum |
Q37592449 | Restructuring of basal ganglia circuitry and associated behaviors triggered by low striatal D2 receptor expression: implications for substance use disorders. |
Q36211286 | Reversal of quinpirole inhibition of ventral tegmental area neurons is linked to the phosphatidylinositol system and is induced by agonists linked to G(q). |
Q28567966 | Reversal of the expression pattern of Aldolase C mRNA in Purkinje cells and Ube 1x mRNA in Golgi cells by a dopamine D1 receptor agonist injections in the methamphetamine sensitized-rat cerebellum |
Q48943054 | Role of vesicle pools in action potential pattern-dependent dopamine overflow in rat striatum in vivo |
Q42700995 | Sex Differences in Midbrain Dopamine D2-Type Receptor Availability and Association with Nicotine Dependence |
Q34646377 | Stimulating and inhibitory effects of the dopamine "stabilizer" (-)-OSU6162 on dopamine D2 receptor function in vitro |
Q28138018 | Structure, alternative splicing, and expression of the human RGS9 gene |
Q39895376 | Studies on the role of the receptor protein motifs possibly involved in electrostatic interactions on the dopamine D1 and D2 receptor oligomerization |
Q46562595 | Subcellular localization of the dopamine D2 receptor and coexistence with the calcium-binding protein neuronal calcium sensor-1 in the primate prefrontal cortex |
Q34317550 | Targeting the dopamine D1 receptor in schizophrenia: insights for cognitive dysfunction |
Q39570856 | The Conserved Arginine Cluster in the Insert of the Third Cytoplasmic Loop of the Long Form of the D₂ Dopamine Receptor (D2L-R) Acts as an Intracellular Retention Signal |
Q33579769 | The dopamine receptor D2 (DRD2) SNP rs1076560 is associated with opioid addiction |
Q41871692 | The histamine autoreceptor is a short isoform of the H₃ receptor |
Q33821967 | The interrelationship of dopamine D2-like receptor availability in striatal and extrastriatal brain regions in healthy humans: a principal component analysis of [18F]fallypride binding |
Q33725853 | The physiological approach: functional architecture of working memory and disordered cognition in schizophrenia |
Q38181840 | The role of D2-autoreceptors in regulating dopamine neuron activity and transmission |
Q36627836 | The role of mesocorticolimbic dopamine in regulating interactions between drugs of abuse and social behavior. |
Q48402642 | Up-regulation of dopamine D(2)L mRNA levels in the ventral tegmental area and dorsal striatum of amphetamine-sensitized C57BL/6 mice: role of Ca(v)1.3 L-type Ca(2+) channels. |
Q38743208 | Validation of dopamine receptor DRD1 and DRD2 antibodies using receptor deficient mice. |
Q53433916 | [18F]fallypride characterization of striatal and extrastriatal D2/3 receptors in Parkinson's disease. |
Q35913120 | mRNA transcript diversity creates new opportunities for pharmacological intervention |
Search more.